These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2810684)

  • 1. Long-term angiographic follow-up results in patients undergoing percutaneous transluminal coronary angioplasty.
    Mikuriya Y; Wakayama K; Kadota M; Matsumoto Y; Tamura A; Yano S; Kanzaki K; Kataoka H
    Jpn Circ J; 1989 Jul; 53(7):728-34. PubMed ID: 2810684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression of coronary artery disease in patients receiving percutaneous transluminal coronary angioplasty: angiographic comparison of angioplasty and non-angioplasty sites.
    Ohtani R; Hiasa Y
    Intern Med; 1995 Jul; 34(7):611-7. PubMed ID: 7496068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early decrease in minimal luminal diameter after successful percutaneous transluminal coronary angioplasty predicts late restenosis.
    Rodriguez A; Santaera O; Larribeau M; Sosa MI; Palacios IF
    Am J Cardiol; 1993 Jun; 71(16):1391-5. PubMed ID: 8517382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of coronary vessel size on renarrowing process and late angiographic outcome after successful balloon angioplasty.
    Foley DP; Melkert R; Serruys PW
    Circulation; 1994 Sep; 90(3):1239-51. PubMed ID: 8087933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical implications of late proven patency after successful coronary angioplasty.
    Weintraub WS; Ghazzal ZM; Cohen CL; Douglas JS; Liberman H; Morris DC; King SB
    Circulation; 1991 Aug; 84(2):572-82. PubMed ID: 1860202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Luminal narrowing after percutaneous transluminal coronary angioplasty. A study of clinical, procedural, and lesional factors related to long-term angiographic outcome. Coronary Artery Restenosis Prevention on Repeated Thromboxane Antagonism (CARPORT) Study Group.
    Rensing BJ; Hermans WR; Vos J; Tijssen JG; Rutch W; Danchin N; Heyndrickx GR; Mast EG; Wijns W; Serruys PW
    Circulation; 1993 Sep; 88(3):975-85. PubMed ID: 8353925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of cilostazol on restenosis after percutaneous coronary balloon angioplasty.
    Tsuchikane E; Fukuhara A; Kobayashi T; Kirino M; Yamasaki K; Kobayashi T; Izumi M; Otsuji S; Tateyama H; Sakurai M; Awata N
    Circulation; 1999 Jul; 100(1):21-6. PubMed ID: 10393676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Luminal narrowing after percutaneous transluminal coronary angioplasty. A multivariate analysis of clinical, procedural and lesion related factors affecting long-term angiographic outcome in the PARK study. Post-Angioplasty Restenosis Ketanserin.
    Melkert R; Violaris AG; Serruys PW
    J Invasive Cardiol; 1994 Jun; 6(5):160-71. PubMed ID: 10155065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient, lesion, and procedural variables as risk factors for luminal re-narrowing after successful coronary angioplasty: a quantitative analysis in 653 patients with 778 lesions. Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.
    Hermans WR; Rensing BJ; Foley DP; Tijssen JG; Rutsch W; Emanuelsson H; Danchin N; Wijns W; Chappuis F; Serruys PW
    J Cardiovasc Pharmacol; 1993; 22 Suppl 4():S45-57. PubMed ID: 7523772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and angiographic results of transluminal extraction coronary atherectomy in saphenous vein bypass grafts.
    Safian RD; Grines CL; May MA; Lichtenberg A; Juran N; Schreiber TL; Pavlides G; Meany TB; Savas V; O'Neill WW
    Circulation; 1994 Jan; 89(1):302-12. PubMed ID: 8281662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute and one year follow-up results after vessel size adapted PTCA using intracoronary ultrasound.
    Haase KK; Athanasiadis A; Mahrholdt H; Treusch A; Wullen B; Jaramillo C; Baumbach A; Voelker W; Meisner C; Karsch KR
    Eur Heart J; 1998 Feb; 19(2):263-72. PubMed ID: 9519320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal coronary balloon angioplasty with provisional stenting versus primary stent (OCBAS): immediate and long-term follow-up results.
    Rodríguez A; Ayala F; Bernardi V; Santaera O; Marchand E; Pardiñas C; Mauvecin C; Vogel D; Harrell LC; Palacios IF
    J Am Coll Cardiol; 1998 Nov; 32(5):1351-7. PubMed ID: 9809947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiologic response to gain and loss in coronary minimal luminal diameter in patients treated with coronary angioplasty: prediction of restenosis on the basis of exercise capacity.
    Jørgensen B; Simonsen S; Endresen K; Forfang K; Egeland T; Thaulow E
    Am Heart J; 2000 Mar; 139(3):482-90. PubMed ID: 10689263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term angiographic and clinical outcome after percutaneous transluminal coronary angioplasty and intracoronary radiation therapy in humans.
    Condado JA; Waksman R; Gurdiel O; Espinosa R; Gonzalez J; Burger B; Villoria G; Acquatella H; Crocker IR; Seung KB; Liprie SF
    Circulation; 1997 Aug; 96(3):727-32. PubMed ID: 9264475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary angioplasty in cardiac transplant recipients.
    Swan JW; Norell M; Yacoub M; Mitchell AG; Ilsley C
    Eur Heart J; 1993 Jan; 14(1):65-70. PubMed ID: 8432294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Latin American randomized trial of balloon angioplasty vs coronary stenting for small vessels (LASMAL): immediate and long-term results.
    Rodriguez A; Rodríguez Alemparte M; Fernández Pereira C; Sampaolesi A; da Rocha Loures Bueno R; Vigo F; Obregón A; Palacios IF;
    Am J Med; 2005 Jul; 118(7):743-51. PubMed ID: 15989908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiographic follow-up results of a randomized study on angioplasty versus bypass surgery (GABI trial). GABI Study Group.
    Rupprecht HJ; Hamm C; Ischinger T; Dietz U; Reimers J; Meyer J
    Eur Heart J; 1996 Aug; 17(8):1192-8. PubMed ID: 8869860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergent use of balloon-expandable coronary artery stenting for failed percutaneous transluminal coronary angioplasty.
    Herrmann HC; Buchbinder M; Clemen MW; Fischman D; Goldberg S; Leon MB; Schatz RA; Tierstein P; Walker CM; Hirshfeld JW
    Circulation; 1992 Sep; 86(3):812-9. PubMed ID: 1516193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of epoprostenol (prostacyclin, PGI2) to inhibit platelet aggregation and to prevent restenosis after coronary angioplasty: results of a randomised placebo controlled trial.
    Gershlick AH; Spriggins D; Davies SW; Syndercombe Court YD; Timmins J; Timmis AD; Rothman MT; Layton C; Balcon R
    Br Heart J; 1994 Jan; 71(1):7-15. PubMed ID: 8297699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphologic changes during follow-up after successful percutaneous transluminal coronary balloon angioplasty: quantitative angiographic analysis in 778 lesions--further evidence for the restenosis paradox. MERCATOR Study Group (Multicenter European Research trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis).
    Hermans WR; Foley DP; Rensing BJ; Serruys PW
    Am Heart J; 1994 Mar; 127(3):483-94. PubMed ID: 8122593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.